For patients who have chronic lymphocytic leukemia (CLL), experiencing Richter transformation with central nervous system ...

Incyte (Nasdaq: INCY) on Thursday unveiled breakthrough results from a pivotal late-stage cancer trial that could redefine ...

Integration of targeted therapies and immunotherapies offers new hope, enhancing survival rates and quality of life. Patients with mantle cell lymphoma experienced better survival rates when treated ...

Larry Vandersall has defied medical odds for nearly a decade. His secret? Faith, family, and an unshakeable positive attitude ...

Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to a new study, ...

When most people think about aging, they imagine a linear progression towards an inevitable end. They think in terms of birthdays, knowing that the more candles on the cake, the more we should ...

Primary central nervous system T-cell lymphoma (PCNS-TCL) is an exceptionally rare entity, representing less than 5% of all PCNSLs. Its diagnosis is frequently delayed due to nonspecific radiologic ...

Gary Woodland not only had his health to prioritize after brain surgery, but suddenly his dad was fighting for his life after ...

MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...

Please provide your email address to receive an email when new articles are posted on . The addition of epcoritamab to rituximab and lenalidomide improved PFS and response rate. The regimen is a ...